|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky 显示文摘 | Hopenhayn -Rich C Stump ML Browning SR | 2002 | Arch Environ Contam Toxicol2002，42，1： | 1 |
| 2 | Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction 显示文摘 | Bovill EG Terrin ML Stump DC | 1991 | Ann Intern Med1991，115，4： | 1 |
| 3 | Hemogghagic events duringtherapy with recombinant tissue-type plasminogen activator,heparin, and aspirin for acute myocardial infarction, result of theThrombolysis in Myocardial Infarction (TIMI) Phase II Trial 显示文摘 | Bovill EG Terrin ML Stump DC | 1991 | Ann Intern Med1991，115，4： | 1 |
| 4 | Regional Assessment of Atrazine Exposure and Incidence of Breast and Ovarian Cancers in Kentucky显示文摘 | Hopenhayn Rich C Stump ML Browning SR | 2002 | Archives of Environmental Contamination and Toxicology2002，42，1： | 1 |
| 5 | For the TIMI investigators hemorrhagic events during therapy with recombinant tissue type plasminogen activator, heparin and aspirin for acute myocardial infarction显示文摘 | Bovill EG Terrin ML Stump DC | 1991 | Ann Intern Med1991，115，： | 1 |
| 6 | Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction显示文摘 | Bovill EG Terrin ML Stump DC | 1991 | Ann Intern Med1991，115，4： | 1 |
| 7 | Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator,heparin,and aspirin for acute myocardial infarction:Results of the Thrombolysis in Myocardial Infarction (TIMI),Phase ⅡTrial显示文摘 | Bovill EG Terrin ML Stump DC | | 0，，04： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员